DraftKings: Consensus Estimates For Q1 2021

DraftKings (NASDAQ: DKNG) will be reporting its first quarter financial results on May 7th before market open. Analysts have a consensus $73.50 12-month price target on the company, via a total of 26 analysts, with five analysts having strong buy ratings. 13 analysts meanwhile have buy ratings, seven analysts have hold rating and one analyst has a sell rating. The street high comes from Loop Capital with a $105 price target, and the lowest target sits at $41 from Berenberg.

Only 20 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 20 analysts is $232.83 million; this number has been revised higher from $188.66 million at the start of the year. The highest revenue estimate is $321.62 million, while the lowest is $197.7 million.

The analyst consensus for net income for the first quarter is -$178.17 million, which is down since the start of the year. The highest net income estimate is -$131 million, while the lowest is -$321.70 million.

Onto EBITDA estimates, there are currently only 17 analysts who have first-quarter EBITDA estimates. The mean is currently -$139.53 million, with this number having been revised lower from -$72 million at the start of the year. The street high estimate currently sits at -$117.33 million in EBITDA and the lowest is -$163.37 million.

Analysts estimate that quarterly earnings per share will come in at -$0.41, with this number being revised downwards from -$0.27 at the start of the year. Street high is -$0.29 and the lowest estimate is -$0.81 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Gold & Silver Just Added $2 Billion to This Project | Aya Gold – Bourmadine PEA

Recommended

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Japan Gold Lands $50 Million in Committed Capital Through Solidcore Alliance

Related News

Ayr Strategies: Canaccord Raises Price Target To $60

Late last week, Canaccord raised Ayr Strategies’ (CSE: AYR.a) 12-month price target to C$60 from...

Tuesday, January 19, 2021, 11:46:00 AM

Filo Mining Sees BMO Lift Price Target To $20 After Assay Results

On January 19th, Filo Mining (TSX: FIL) reported their assay results from hole FSDH054. The...

Saturday, January 22, 2022, 11:07:00 AM

BMO Raises Jazz Pharmaceuticals Price Target To US$205

It was announced last week wednesday that Jazz Pharmaceuticals (NASDAQ: JAZZ) would be acquiring GW...

Monday, February 8, 2021, 10:40:00 AM

Air Canada: BMO Reinstates Coverage With $33 Price Target

Last week, BMO Capital Markets reinstated their coverage on Air Canada (TSX: AC) after discontinuing...

Saturday, March 6, 2021, 10:17:00 AM

Sundial Growers: Canaccord Initiates Coverage With US$0.30 Price Target

This morning, Canaccord Genuity initiated coverage on Sundial Growers (NASDAQ: SNDL) with a US$0.30 price...

Monday, November 16, 2020, 12:12:19 PM